Faropenem Sodium is used in trials studying the treatment of Tuberculosis, Pulmonary Tuberculosis, and Community Acquired Pneumonia.. Reference standards of Faropenem Sodium API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below
Faropenem Sodium
Catalogue No.:PA 06 04000
CAS :
Molecular Formula : C12H14NNaO5S
Molecular Weight : 307.30
Faropenem Sodium Salt Hemipentahydrate
Catalogue No.:PA 06 04510
Molecular Formula : C12H14NNaO5S•5/2H2O
Molecular Weight : 352.34
(R)-5-(Tetrahydrofuran-2-yl)thiazole-4-carboxylic Acid
Catalogue No.:PA 06 0041000
Molecular Formula : C8H9NO3S
Molecular Weight : 199.22
(5R,6S)-6-((R)-1-Hydroxyethyl)-7-oxo-3-((S)-tetrahydrofuran-2-yl)-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid, Sodium Salt
Catalogue No.:PA 06 0041001
(5R,6S)-6-Acetyl-7-oxo-3-((R)-tetrahydrofuran-2-yl)-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic Acid
Catalogue No.:PA 06 0041002
Molecular Formula : C12H13NO5S
Molecular Weight : 283.3
(S,Z)-2-((1S,2R)-1-Carboxy-2-hydroxypropyl)-5-(4-hydroxybutylidene)-2,5-dihydrothiazole-4-carboxylic Acid
Catalogue No.:PA 06 0041003
Molecular Formula : C12H17NO6S
Molecular Weight : 303.33
(R,Z)-2-((1R,2S)-1-Carboxy-2-hydroxypropyl)-5-(4-hydroxybutylidene)-2,5-dihydrothiazole-4-carboxylic Acid
Catalogue No.:PA 06 0041004
(R)-3-((5-((R)-Tetrahydrofuran-2-yl)thiazole-4-carbonyl)oxy)butanoic Acid
Catalogue No.:PA 06 0041005
Molecular Formula : C12H15NO5S
Molecular Weight : 285.31
(Z)-4-Formyl-2-(4-hydroxybutylidene)-5-methyl-2,5-dihydrothiophene-3-carboxylic Acid
Catalogue No.:PA 06 0041006
Molecular Formula : C11H14O4S
Molecular Weight : 242.29
(5R,6S)-6-((R)-1-(((R)-3-Hydroxybutanoyl)oxy)ethyl)-7-oxo-3-((R)-tetrahydrofuran-2-yl)-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic Acid
Catalogue No.:PA 06 0041007
Molecular Formula : C16H21NO7S
Molecular Weight : 371.4
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
